Isoxazole substituted nitroimidazoles
US4010176A · kind A · utility
20Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 1975 |
| Grant date | Mar 1, 1977 |
| Priority date | — |
| Expiry date | Jul 30, 1995 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/95
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel substituted nitroimidazoles are provided, for example, 2-(4,5-substituted-isoxazol-3-yl)-1-substituted-5-nitroimidazole; 2-(4,5-disubstituted-.DELTA..sup.2 -isoxazolin-3-yl)-1-substituted-5-nitroimidazole; or 2-(4,5-disubstituted-2-loweralkyl-isoxazolidin-3-yl)-1-substituted-5-nitro imidazole. These compounds have antibacterial and antiprotozoal activity, especially against human and animal trypanosomiasis and trichomoniasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.